fda bpc-157 compounding restrictions Approval Status: Is It Approved for Human Use? FDA to Reconsider BPC-157 and
Description
You should not take BPC-157 if: You have a personal or family history of cancer: BPC-157 cannot differentiate between healthy tissue and tumor cells
the injection instructions were also simple to follow
It has poor metabolic stability, a short half-life in circulation, and limited bioavailability when administered systemically
Z Med Clinic & Med Spa
